Dosing guidelines for fluconazole in patients with renal failure
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Fluconazole is a widely used drug that inhibits the synthesis of fungal cell membranes [1,2]. Its elimination is predominantly via renal excretion with most of the dose recovered in urine as an unchanged and active drug. As a result, drug pharmacokinetics are altered in patients with renal failure and it is essential to establish guidelines on how to handle this drug in those patients. Furthermore, in dialysis patients, the removal of the drug in the dialysate has to be elucidated to determine whether fluconazole should be administered after the session or not. A review of the literature was thus performed and analysis of the retrieved data permitted to establish dosage adjustment guidelines for fluconazole in patients with renal failure. The oral bioavaibility of fluconazole is >90%, which enables us to administer it with similar doses by i.v. and oral routes. Neither food nor gastric pH modifications have a significant effect on its oral absorption [3,4]. Fluconazole has low plasma protein binding (11%) and its apparent volume of distribution is 0.8 l/kg [5], which approximates total body water. The primary route of elimination is via renal excretion. Eighty per cent of an administered dose is recovered in urine as unchanged and active drug and 11% as the glucuronide and N-oxide metabolites, which are both inactive and probably come from metabolism in the liver by cytochrome P450 3A4 enzymes [6–8]. Over the range of 100–400 mg orally, the variation of fluconazole maximum plasma concentration (Cmax) and area under the concentration–time curve (AUC) are proportional to the administered dose, whereas the elimination half-life (30 h) and the time of maximal concentration remain constant (0.5–6 h). This indicates the linearity of the pharmacokinetics of fluconazole for oral doses ranging from 100 to 400 mg [3]. After doses of 200 and 400 mg, the plasma concentrations of fluconazole were, respectively, 4.6 and 9 mg/l at steady state, which is reached 4–5 days after administration of multiple doses and in ∼2 days when given a loading dose representing the double of the maintenance dose: 400 or 800 mg, respectively. This pharmacokinetic profile enables us to obtain good results against sensitive or usually sensitive strains, as the minimum inhibitory concentrations (MICs) 90 of fluconazole are 1 mg/l for Candida albicans [9] and 16 mg/l for Candida glabrata [9,10] and Cryptococcus neoformans [11] (Table 1). In clinical practice, recommended efficient concentrations of fluconazole are 7–8 mg/l for Candida’s infections and 15–20 mg/l for severe infections [12].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, S. M., & Clissold, S. P. (1990) · Drugs · doi:10.2165/00003495-199039060-00006 · Cited by 661
Cited by
Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R., & Hope, W. W. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt508 · Cited by 716
Nett, J. E., & Andes, D. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.012 · Cited by 351
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2009) · Critical Care · doi:10.1186/cc7964 · Cited by 93
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53
“FLC levels reach peak serum concentration 1–6 h after administration and remain in the system for days (elimination half-life is ∼30 h in individuals with functioning kidneys [Cousin 2003]).”
Metadata
- Authors
- Cousin, L.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 18
- Issue
- 11
- Pages
- 2227-2231
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2107333376
- Cited by
- 44
- References
- 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dosing guidelines for fluconazole in patients with renal failure. https://app.cochat.ai/papers/10.1093/ndt/gfg363
- The paper
- Cousin, L. (2003). Dosing guidelines for fluconazole in patients with renal failure. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfg363
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.